DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Generation of knock-in primary human T cells using Cas9 ribonucleoproteins

Abstract

T-cell genome engineering holds great promise for cell-based therapies for cancer, HIV, primary immune deficiencies, and autoimmune diseases, but genetic manipulation of human T cells has been challenging. Improved tools are needed to efficiently “knock out” genes and “knock in” targeted genome modifications to modulate T-cell function and correct disease-associated mutations. CRISPR/Cas9 technology is facilitating genome engineering in many cell types, but in human T cells its efficiency has been limited and it has not yet proven useful for targeted nucleotide replacements. Here we report efficient genome engineering in human CD4+ T cells using Cas9:single-guide RNA ribonucleoproteins (Cas9 RNPs). Cas9 RNPs allowed ablation of CXCR4, a coreceptor for HIV entry. Cas9 RNP electroporation caused up to ~40% of cells to lose high-level cell-surface expression of CXCR4, and edited cells could be enriched by sorting based on low CXCR4 expression. Importantly, Cas9 RNPs paired with homology-directed repair template oligonucleotides generated a high frequency of targeted genome modifications in primary T cells. Targeted nucleotide replacement was achieved in CXCR4 and PD-1 (PDCD1), a regulator of T-cell exhaustion that is a validated target for tumor immunotherapy. Deep sequencing of a target site confirmed that Cas9 RNPs generated knock-in genome modifications with up tomore » ~20% efficiency, which accounted for up to approximately one-third of total editing events. These results establish Cas9 RNP technology for diverse experimental and therapeutic genome engineering applications in primary human T cells.« less

Authors:
 [1];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [3];  [4]
  1. Univ. of California, San Francisco, CA (United States)
  2. Univ. of California, Berkeley, CA (United States)
  3. Univ. of California, San Francisco, CA (United States); Univ. of California, Berkeley, CA (United States); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  4. Univ. of California, San Francisco, CA (United States); Univ. of California, Berkeley, CA (United States)
Publication Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1221821
Grant/Contract Number:  
AC02-05CH11231
Resource Type:
Accepted Manuscript
Journal Name:
Proceedings of the National Academy of Sciences of the United States of America
Additional Journal Information:
Journal Volume: 112; Journal Issue: 33; Journal ID: ISSN 0027-8424
Publisher:
National Academy of Sciences, Washington, DC (United States)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; CRISPR/Cas9; genome engineering; Cas9 ribonucleoprotein; RNP primary; human T cells

Citation Formats

Schumann, Kathrin, Lin, Steven, Boyer, Eric, Simeonov, Dimitre R., Subramaniam, Meena, Gate, Rachel E., Haliburton, Genevieve E., Ye, Chun J., Bluestone, Jeffrey A., Doudna, Jennifer A., and Marson, Alexander. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. United States: N. p., 2015. Web. doi:10.1073/pnas.1512503112.
Schumann, Kathrin, Lin, Steven, Boyer, Eric, Simeonov, Dimitre R., Subramaniam, Meena, Gate, Rachel E., Haliburton, Genevieve E., Ye, Chun J., Bluestone, Jeffrey A., Doudna, Jennifer A., & Marson, Alexander. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. United States. https://doi.org/10.1073/pnas.1512503112
Schumann, Kathrin, Lin, Steven, Boyer, Eric, Simeonov, Dimitre R., Subramaniam, Meena, Gate, Rachel E., Haliburton, Genevieve E., Ye, Chun J., Bluestone, Jeffrey A., Doudna, Jennifer A., and Marson, Alexander. Mon . "Generation of knock-in primary human T cells using Cas9 ribonucleoproteins". United States. https://doi.org/10.1073/pnas.1512503112. https://www.osti.gov/servlets/purl/1221821.
@article{osti_1221821,
title = {Generation of knock-in primary human T cells using Cas9 ribonucleoproteins},
author = {Schumann, Kathrin and Lin, Steven and Boyer, Eric and Simeonov, Dimitre R. and Subramaniam, Meena and Gate, Rachel E. and Haliburton, Genevieve E. and Ye, Chun J. and Bluestone, Jeffrey A. and Doudna, Jennifer A. and Marson, Alexander},
abstractNote = {T-cell genome engineering holds great promise for cell-based therapies for cancer, HIV, primary immune deficiencies, and autoimmune diseases, but genetic manipulation of human T cells has been challenging. Improved tools are needed to efficiently “knock out” genes and “knock in” targeted genome modifications to modulate T-cell function and correct disease-associated mutations. CRISPR/Cas9 technology is facilitating genome engineering in many cell types, but in human T cells its efficiency has been limited and it has not yet proven useful for targeted nucleotide replacements. Here we report efficient genome engineering in human CD4+ T cells using Cas9:single-guide RNA ribonucleoproteins (Cas9 RNPs). Cas9 RNPs allowed ablation of CXCR4, a coreceptor for HIV entry. Cas9 RNP electroporation caused up to ~40% of cells to lose high-level cell-surface expression of CXCR4, and edited cells could be enriched by sorting based on low CXCR4 expression. Importantly, Cas9 RNPs paired with homology-directed repair template oligonucleotides generated a high frequency of targeted genome modifications in primary T cells. Targeted nucleotide replacement was achieved in CXCR4 and PD-1 (PDCD1), a regulator of T-cell exhaustion that is a validated target for tumor immunotherapy. Deep sequencing of a target site confirmed that Cas9 RNPs generated knock-in genome modifications with up to ~20% efficiency, which accounted for up to approximately one-third of total editing events. These results establish Cas9 RNP technology for diverse experimental and therapeutic genome engineering applications in primary human T cells.},
doi = {10.1073/pnas.1512503112},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 33,
volume = 112,
place = {United States},
year = {Mon Jul 27 00:00:00 EDT 2015},
month = {Mon Jul 27 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 456 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Adoptive Immunotherapy for Cancer or Viruses
journal, March 2014


Helper T-cell identity and evolution of differential transcriptomes and epigenomes
journal, February 2013

  • Vahedi, Golnaz; C. Poholek, Amanda; Hand, Timothy W.
  • Immunological Reviews, Vol. 252, Issue 1
  • DOI: 10.1111/imr.12037

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
journal, May 1996


Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
journal, August 2011

  • Porter, David L.; Levine, Bruce L.; Kalos, Michael
  • New England Journal of Medicine, Vol. 365, Issue 8
  • DOI: 10.1056/NEJMoa1103849

Adoptive immunotherapy for cancer: harnessing the T cell response
journal, March 2012

  • Restifo, Nicholas P.; Dudley, Mark E.; Rosenberg, Steven A.
  • Nature Reviews Immunology, Vol. 12, Issue 4
  • DOI: 10.1038/nri3191

Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
journal, November 2014


Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases
journal, November 2013


Targeted genome editing in human repopulating haematopoietic stem cells
journal, May 2014

  • Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia
  • Nature, Vol. 510, Issue 7504
  • DOI: 10.1038/nature13420

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
journal, March 2014

  • Tebas, Pablo; Stein, David; Tang, Winson W.
  • New England Journal of Medicine, Vol. 370, Issue 10
  • DOI: 10.1056/NEJMoa1300662

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
journal, February 2009

  • Hütter, Gero; Nowak, Daniel; Mossner, Maximilian
  • New England Journal of Medicine, Vol. 360, Issue 7
  • DOI: 10.1056/NEJMoa0802905

Genetic and epigenetic fine mapping of causal autoimmune disease variants
journal, October 2014

  • Farh, Kyle Kai-How; Marson, Alexander; Zhu, Jiang
  • Nature, Vol. 518, Issue 7539
  • DOI: 10.1038/nature13835

CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
journal, December 2013


Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
journal, July 2013


The new frontier of genome engineering with CRISPR-Cas9
journal, November 2014


Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
journal, December 2014


Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
journal, April 2015


Development and Applications of CRISPR-Cas9 for Genome Engineering
journal, June 2014


Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
journal, June 1998

  • Zou, Yong-Rui; Kottmann, Andreas H.; Kuroda, Masahiko
  • Nature, Vol. 393, Issue 6685
  • DOI: 10.1038/31269

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
journal, April 2014


Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
journal, October 2014

  • Zuris, John A.; Thompson, David B.; Shu, Yilai
  • Nature Biotechnology, Vol. 33, Issue 1
  • DOI: 10.1038/nbt.3081

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
journal, January 2014


Double-Strand Break End Resection and Repair Pathway Choice
journal, December 2011


A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
journal, January 1996


Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
journal, April 2015


Helper T-cell identity and evolution of differential transcriptomes and epigenomes
journal, February 2013

  • Vahedi, Golnaz; C. Poholek, Amanda; Hand, Timothy W.
  • Immunological Reviews, Vol. 252, Issue 1
  • DOI: 10.1111/imr.12037

Double-Strand Break End Resection and Repair Pathway Choice
journal, December 2011


Works referencing / citing this record:

The next generation of CRISPR–Cas technologies and applications
journal, May 2019

  • Pickar-Oliver, Adrian; Gersbach, Charles A.
  • Nature Reviews Molecular Cell Biology, Vol. 20, Issue 8
  • DOI: 10.1038/s41580-019-0131-5

Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage
journal, February 2017


Genome editing by natural and engineered CRISPR-associated nucleases
journal, June 2018


CRISPR/Cas9 genome editing in human hematopoietic stem cells
journal, January 2018

  • Bak, Rasmus O.; Dever, Daniel P.; Porteus, Matthew H.
  • Nature Protocols, Vol. 13, Issue 2
  • DOI: 10.1038/nprot.2017.143

Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy
journal, December 2018


Genome editing of bread wheat using biolistic delivery of CRISPR/Cas9 in vitro transcripts or ribonucleoproteins
journal, February 2018


Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
journal, April 2017


Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
journal, June 2019

  • Schober, Kilian; Müller, Thomas R.; Gökmen, Füsun
  • Nature Biomedical Engineering, Vol. 3, Issue 12
  • DOI: 10.1038/s41551-019-0409-0

Helios enhances the preferential differentiation of human fetal CD4 + naïve T cells into regulatory T cells
journal, November 2019


Application of Genome Editing Techniques in Immunology
journal, January 2018

  • Zych, Agata O.; Bajor, Malgorzata; Zagozdzon, Radoslaw
  • Archivum Immunologiae et Therapiae Experimentalis, Vol. 66, Issue 4
  • DOI: 10.1007/s00005-018-0504-z

Therapeutic applications of CRISPR RNA-guided genome editing
journal, August 2016

  • Koo, Taeyoung; Kim, Jin-Soo
  • Briefings in Functional Genomics, Vol. 16, Issue 1
  • DOI: 10.1093/bfgp/elw032

Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
journal, December 2019

  • Chen, Fengqian; Alphonse, Martin; Liu, Qi
  • WIREs Nanomedicine and Nanobiotechnology
  • DOI: 10.1002/wnan.1609

The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis
journal, March 2018

  • Melamed, Anat; Yaguchi, Hiroko; Miura, Michi
  • eLife
  • DOI: 10.1101/277335

CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines: CRISPR in EBV-Transformed B-Cells
journal, January 2018

  • Jiang, Sizun; Wang, Liang Wei; Walsh, Michael J.
  • Current Protocols in Molecular Biology, Vol. 121, Issue 1
  • DOI: 10.1002/cpmb.51

Emerging CRISPR/Cas9 applications for T-cell gene editing
journal, April 2019

  • Preece, Roland; Georgiadis, Christos
  • Emerging Topics in Life Sciences, Vol. 3, Issue 3
  • DOI: 10.1042/ETLS20180144

CRISPR/Cas9 Genome Editing Using Gold-Nanoparticle-Mediated Laserporation
journal, May 2018

  • Bošnjak, Berislav; Permanyer, Marc; Sethi, Maya K.
  • Advanced Biosystems, Vol. 2, Issue 11
  • DOI: 10.1002/adbi.201700184

Metabolic reprogramming of human CD8 + memory T cells through loss of SIRT1
journal, November 2017

  • Jeng, Mark Y.; Hull, Philip A.; Fei, Mingjian
  • The Journal of Experimental Medicine, Vol. 215, Issue 1
  • DOI: 10.1084/jem.20161066

Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
journal, July 2018


Delivery technologies for genome editing
journal, March 2017

  • Yin, Hao; Kauffman, Kevin J.; Anderson, Daniel G.
  • Nature Reviews Drug Discovery, Vol. 16, Issue 6
  • DOI: 10.1038/nrd.2016.280

An efficient electroporation protocol for the genetic modification of mammalian cells
journal, September 2016

  • Chicaybam, Leonardo; Barcelos, Camila; Peixoto, Barbara
  • Frontiers in Bioengineering and Biotechnology
  • DOI: 10.1101/073387

CRISPR-delivery particles targeting nuclear receptor–interacting protein 1 ( Nrip1 ) in adipose cells to enhance energy expenditure
journal, September 2018

  • Shen, Yuefei; Cohen, Jessica L.; Nicoloro, Sarah M.
  • Journal of Biological Chemistry, Vol. 293, Issue 44
  • DOI: 10.1074/jbc.ra118.004554

Transfection by Electroporation
journal, January 2018

  • Potter, Huntington; Heller, Richard
  • Current Protocols in Molecular Biology, Vol. 121, Issue 1
  • DOI: 10.1002/cpmb.48

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
journal, November 2017

  • Yin, Hao; Song, Chun-Qing; Suresh, Sneha
  • Nature Biotechnology, Vol. 35, Issue 12
  • DOI: 10.1038/nbt.4005

Recent advances in DNA-free editing and precise base editing in plants
journal, November 2017

  • Zhang, Yi; Gao, Caixia
  • Emerging Topics in Life Sciences, Vol. 1, Issue 2
  • DOI: 10.1042/etls20170021

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
journal, December 2018


Delivering CRISPR: a review of the challenges and approaches
journal, January 2018


Highly efficient and versatile plasmid-based gene editing in primary T cells
posted_content, January 2018

  • Kornete, Mara; Marone, Romina; Jeker, Lukas T.
  • The Journal of Immunology
  • DOI: 10.1101/247544

Resources for the design of CRISPR gene editing experiments
journal, November 2015


Viable and efficient electroporation-based genetic manipulation of unstimulated human T cells
posted_content, October 2019

  • Aksoy, Pinar; Aksoy, Bülent Arman; Czech, Eric
  • BioRxiv
  • DOI: 10.1101/466243

Cancer diagnosis and immunotherapy in the age of CRISPR
journal, December 2018

  • Cook, Peter J.; Ventura, Andrea
  • Genes, Chromosomes and Cancer, Vol. 58, Issue 4
  • DOI: 10.1002/gcc.22702

CRISPR/Cas9: A tool for immunological research
journal, February 2018

  • Hochheiser, Katharina; Kueh, Andrew J.; Gebhardt, Thomas
  • European Journal of Immunology, Vol. 48, Issue 4
  • DOI: 10.1002/eji.201747131

Recent challenges and advances in genetically-engineered cell therapy
journal, December 2017

  • Yong, Seok-Beom; Chung, Jee Young; Song, Yoonsung
  • Journal of Pharmaceutical Investigation, Vol. 48, Issue 2
  • DOI: 10.1007/s40005-017-0381-1

CRISPR/Cas9 technology as a potent molecular tool for gene therapy
journal, December 2018

  • Karimian, Ansar; Azizian, Khalil; Parsian, Hadi
  • Journal of Cellular Physiology, Vol. 234, Issue 8
  • DOI: 10.1002/jcp.27972

An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
journal, January 2018

  • Dewari, Pooran Singh; Southgate, Benjamin; Mccarten, Katrina
  • eLife
  • DOI: 10.1101/255737

CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna
journal, October 2017


CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
journal, December 2018


HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
journal, June 2018


Engineered T cells: the promise and challenges of cancer immunotherapy
journal, August 2016

  • Fesnak, Andrew D.; June, Carl H.; Levine, Bruce L.
  • Nature Reviews Cancer, Vol. 16, Issue 9
  • DOI: 10.1038/nrc.2016.97

CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
journal, December 2016

  • Liu, Xiaojuan; Zhang, Yongping; Cheng, Chen
  • Cell Research, Vol. 27, Issue 1
  • DOI: 10.1038/cr.2016.142

Resolving mechanisms of immune-mediated disease in primary CD4 T cells.
text, January 2020

  • Bourges, Christophe; Groff, Abigail F.; Burren, Oliver
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.51450

In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
journal, July 2018


Applications of CRISPR systems in respiratory health: Entering a new ‘red pen’ era in genome editing
journal, February 2019


Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
journal, August 2018

  • Shifrut, Eric; Carnevale, Julia; Tobin, Victoria
  • Cell
  • DOI: 10.1101/384776

Primary allogeneic mitochondrial mix (PAMM) transfer/transplant by MitoCeption to address damage in PBMCs caused by ultraviolet radiation
journal, June 2019


The clinical potential of gene editing as a tool to engineer cell‐based therapeutics
journal, January 2020

  • Ashmore‐Harris, Candice; Fruhwirth, Gilbert O.
  • Clinical and Translational Medicine, Vol. 9, Issue 1
  • DOI: 10.1186/s40169-020-0268-z

Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
journal, April 2018


Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing
journal, December 2019


Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
journal, October 2016


GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells
journal, November 2016

  • Fazil, Mobashar Hussain Urf Turabe; Ong, Seow Theng; Chalasani, Madhavi Latha Somaraju
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep37721

Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome
journal, May 2016


Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent
journal, January 2018


Spontaneous HTLV-1 transcription is accompanied by distinct epigenetic changes in the 5′ and 3′ long terminal repeats
journal, January 2018


Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
journal, March 2019

  • Xiao, Qiaoqiao; Guo, Deyin; Chen, Shuliang
  • Frontiers in Cellular and Infection Microbiology, Vol. 9
  • DOI: 10.3389/fcimb.2019.00069

Efficient CRISPR/Cas9 Disruption of Autoimmune-Associated Genes Reveals Key Signaling Programs in Primary Human T Cells
journal, November 2019

  • Anderson, Warren; Thorpe, Jerill; Long, S. Alice
  • The Journal of Immunology, Vol. 203, Issue 12
  • DOI: 10.4049/jimmunol.1900848

Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells
journal, February 2018

  • Kornete, Mara; Marone, Romina; Jeker, Lukas T.
  • The Journal of Immunology, Vol. 200, Issue 7
  • DOI: 10.4049/jimmunol.1701121

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
journal, February 2018

  • Li, Xiaolei; Shao, Changshun; Shi, Yufang
  • Journal of Hematology & Oncology, Vol. 11, Issue 1
  • DOI: 10.1186/s13045-018-0578-4

Genetic editing and interrogation with Cpf1 and caged truncated pre-tRNA-like crRNA in mammalian cells
journal, July 2018


Purity of transferred CD8 + T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP‐1
journal, July 2016

  • Watson, H. Angharad; Dolton, Garry; Ohme, Julia
  • Immunology & Cell Biology, Vol. 94, Issue 8
  • DOI: 10.1038/icb.2016.45

Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo
journal, August 2018


Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci
journal, February 2020


Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing
journal, January 2018


An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells
journal, January 2017

  • Chicaybam, Leonardo; Barcelos, Camila; Peixoto, Barbara
  • Frontiers in Bioengineering and Biotechnology, Vol. 4
  • DOI: 10.3389/fbioe.2016.00099

Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells
journal, October 2018

  • Oh, Soyoung A.; Seki, Akiko; Rutz, Sascha
  • Current Protocols in Immunology, Vol. 124, Issue 1
  • DOI: 10.1002/cpim.69

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
journal, April 2017


Efficient gene knockin in axolotl and its use to test the role of satellite cells in limb regeneration
journal, October 2017

  • Fei, Ji-Feng; Schuez, Maritta; Knapp, Dunja
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 47
  • DOI: 10.1073/pnas.1706855114

CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
journal, May 2018


Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
journal, June 2019

  • Gao, Qianqian; Dong, Xuan; Xu, Qumiao
  • Cancer Medicine, Vol. 8, Issue 9
  • DOI: 10.1002/cam4.2257

Directed evolution of CRISPR-Cas9 to increase its specificity
journal, August 2018


Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
journal, December 2018


Cornerstones of CRISPR–Cas in drug discovery and therapy
journal, December 2016

  • Fellmann, Christof; Gowen, Benjamin G.; Lin, Pei-Chun
  • Nature Reviews Drug Discovery, Vol. 16, Issue 2
  • DOI: 10.1038/nrd.2016.238

Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders
journal, January 2016


CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
journal, December 2018


Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
journal, March 2019


Reprogramming human T cell function and specificity with non-viral genome targeting
journal, July 2018


Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
journal, December 2017

  • Lessard, Samuel; Francioli, Laurent; Alfoldi, Jessica
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 52
  • DOI: 10.1073/pnas.1714640114

Light-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic device
journal, May 2018

  • Mocciaro, Annamaria; Roth, Theodore L.; Bennett, Hayley M.
  • Communications Biology, Vol. 1, Issue 1
  • DOI: 10.1038/s42003-018-0034-6

Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL
journal, March 2018

  • Wu, Yanfang; Li, Xia; Jia, Junying
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 12
  • DOI: 10.1073/pnas.1716439115

Unexpected heterogeneity derived from Cas9 ribonucleoprotein-introduced clonal cells at the HPRT1 locus
journal, February 2018

  • Sakuma, Tetsushi; Mochida, Keiji; Nakade, Shota
  • Genes to Cells, Vol. 23, Issue 4
  • DOI: 10.1111/gtc.12569

Dynamics of T cell activation mediated by eIF3 interactions with T cell receptor mRNAs
posted_content, October 2020


Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation
journal, June 2019

  • Campbell, Lee A.; Richie, Christopher T.; Maggirwar, Nishad S.
  • Journal of Neuroimmune Pharmacology, Vol. 14, Issue 4
  • DOI: 10.1007/s11481-019-09856-z

mRNA as novel technology for passive immunotherapy
journal, October 2018

  • Schlake, Thomas; Thess, Andreas; Thran, Moritz
  • Cellular and Molecular Life Sciences, Vol. 76, Issue 2
  • DOI: 10.1007/s00018-018-2935-4

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
journal, October 2017


A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
journal, December 2016

  • Park, Ryan J.; Wang, Tim; Koundakjian, Dylan
  • Nature Genetics, Vol. 49, Issue 2
  • DOI: 10.1038/ng.3741

Efficient genome editing of human natural killer cells by CRISPR RNP
posted_content, September 2018

  • Rautela, Jai; Surgenor, Elliot; Huntington, Nicholas D.
  • BioRxiv
  • DOI: 10.1101/406934

The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
journal, August 2019

  • Sanches-da-Silva, Gabriela De Nardi; Medeiros, Luiza Fonseca Sales; Lima, Fabio Mitsuo
  • International Journal of Genomics, Vol. 2019
  • DOI: 10.1155/2019/8458263

In vitro transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
journal, March 2018

  • Wienert, Beeke; Shin, Jiyung; Zelin, Elena
  • PLOS Biology
  • DOI: 10.1101/275669

Editing the Central Nervous System Through CRISPR/Cas9 Systems
journal, May 2019

  • Cota-Coronado, Agustin; Díaz-Martínez, Néstor Fabián; Padilla-Camberos, Eduardo
  • Frontiers in Molecular Neuroscience, Vol. 12
  • DOI: 10.3389/fnmol.2019.00110

Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues
journal, December 2019


Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes
journal, December 2019

  • Meyer, Lauren K.; Huang, Benjamin J.; Delgado-Martin, Cristina
  • Journal of Clinical Investigation, Vol. 130, Issue 2
  • DOI: 10.1172/jci130189

A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells
journal, March 2018


Guide Swap enables genome-scale pooled CRISPR–Cas9 screening in human primary cells
journal, October 2018


A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
journal, August 2018

  • Vakulskas, Christopher A.; Dever, Daniel P.; Rettig, Garrett R.
  • Nature Medicine, Vol. 24, Issue 8
  • DOI: 10.1038/s41591-018-0137-0

Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
journal, August 2017


The protean world of non-coding RNAs in glioblastoma
journal, May 2019

  • Paulmurugan, Ramasamy; Malhotra, Meenakshi; Massoud, Tarik F.
  • Journal of Molecular Medicine, Vol. 97, Issue 7
  • DOI: 10.1007/s00109-019-01798-6

Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
journal, February 2018

  • Seki, Akiko; Rutz, Sascha
  • Journal of Experimental Medicine, Vol. 215, Issue 3
  • DOI: 10.1084/jem.20171626

Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity
journal, November 2019

  • Baars, Matthijs; Douma, Thera; Simeonov, Dimitre R.
  • European Journal of Immunology
  • DOI: 10.1101/656454

CRISPR-Cas9 technology: applications and human disease modelling
journal, June 2016

  • Torres-Ruiz, Raul; Rodriguez-Perales, Sandra
  • Briefings in Functional Genomics, Vol. 16, Issue 1
  • DOI: 10.1093/bfgp/elw025

CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
journal, March 2019

  • Salas-Mckee, January; Kong, Weimin; Gladney, Whitney L.
  • Human Vaccines & Immunotherapeutics, Vol. 15, Issue 5
  • DOI: 10.1080/21645515.2019.1571893

In vitro and ex vivo strategies for intracellular delivery
journal, October 2016

  • Stewart, Martin P.; Sharei, Armon; Ding, Xiaoyun
  • Nature, Vol. 538, Issue 7624
  • DOI: 10.1038/nature19764

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
journal, February 2017

  • Kim, Kyoungmi; Park, Sung Wook; Kim, Jin Hyoung
  • Genome Research, Vol. 27, Issue 3
  • DOI: 10.1101/gr.219089.116

CRISPR-Cas9: A cornerstone for the evolution of precision medicine
journal, July 2018


CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases
journal, May 2018

  • Antony, Justin S.; Haque, A. K. M. Ashiqul; Lamsfus-Calle, Andrés
  • Advances in Cell and Gene Therapy, Vol. 1, Issue 1
  • DOI: 10.1002/acg2.10

Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery
journal, December 2015

  • Bolukbasi, Mehmet Fatih; Gupta, Ankit; Wolfe, Scot A.
  • Nature Methods, Vol. 13, Issue 1
  • DOI: 10.1038/nmeth.3684

Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection
journal, March 2019

  • Albers, Julian J.; Ammon, Tim; Gosmann, Dario
  • Life Science Alliance, Vol. 2, Issue 2
  • DOI: 10.26508/lsa.201900367

Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci
journal, April 2019

  • Gutierrez-Arcelus, Maria; Baglaenko, Yuriy; Arora, Jatin
  • Nature Genetics
  • DOI: 10.1101/599449

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
journal, February 2019


The epigenetic landscape of T cell exhaustion
journal, October 2016


Humanized model mice by genome editing and engraftment technologies
journal, June 2018


Is autoimmunity the Achilles' heel of cancer immunotherapy?
journal, May 2017

  • June, Carl H.; Warshauer, Jeremy T.; Bluestone, Jeffrey A.
  • Nature Medicine, Vol. 23, Issue 5
  • DOI: 10.1038/nm.4321

T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses
journal, November 2018


Resolving mechanisms of immune‐mediated disease in primary CD 4 T cells
journal, April 2020

  • Bourges, Christophe; Groff, Abigail F.; Burren, Oliver S.
  • EMBO Molecular Medicine, Vol. 12, Issue 5
  • DOI: 10.15252/emmm.202012112

One-step generation of modular CAR-T cells with AAV–Cpf1
journal, February 2019


Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR/Cas9 genome editing
journal, February 2018

  • Ouchi, Yasuo; Patil, Ashwini; Tamura, Yusuke
  • International Immunology, Vol. 30, Issue 4
  • DOI: 10.1093/intimm/dxy006

Chimeric antigen receptor T cell therapy for multiple myeloma
journal, June 2019


The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses
journal, September 2018

  • Gilani, Usman; Shaukat, Memoona; Rasheed, Arisha
  • Journal of Medical Virology, Vol. 91, Issue 1
  • DOI: 10.1002/jmv.25292

CRISPR–Cas: a tool for cancer research and therapeutics
journal, January 2019


Next-generation regulatory T cell therapy
journal, September 2019

  • Ferreira, Leonardo M. R.; Muller, Yannick D.; Bluestone, Jeffrey A.
  • Nature Reviews Drug Discovery, Vol. 18, Issue 10
  • DOI: 10.1038/s41573-019-0041-4

Applications of CRISPR technologies in research and beyond
journal, September 2016

  • Barrangou, Rodolphe; Doudna, Jennifer A.
  • Nature Biotechnology, Vol. 34, Issue 9
  • DOI: 10.1038/nbt.3659

An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
journal, April 2018

  • Dewari, Pooran Singh; Southgate, Benjamin; Mccarten, Katrina
  • eLife, Vol. 7
  • DOI: 10.7554/elife.35069

Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells
journal, November 2019


EfficientCRISPR‐based genome editing using tandem guideRNAs and editable surrogate reporters
journal, June 2018


Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
journal, June 2019

  • Gao, Qianqian; Dong, Xuan; Xu, Qumiao
  • Cancer Medicine, Vol. 8, Issue 9
  • DOI: 10.1002/cam4.2257

Application of Genome Editing Techniques in Immunology
journal, January 2018

  • Zych, Agata O.; Bajor, Malgorzata; Zagozdzon, Radoslaw
  • Archivum Immunologiae et Therapiae Experimentalis, Vol. 66, Issue 4
  • DOI: 10.1007/s00005-018-0504-z

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
journal, April 2017


In vitro transcribed sgRNA causes cell death by inducing interferon release
journal, January 2019


Recent challenges and advances in genetically-engineered cell therapy
journal, December 2017

  • Yong, Seok-Beom; Chung, Jee Young; Song, Yoonsung
  • Journal of Pharmaceutical Investigation, Vol. 48, Issue 2
  • DOI: 10.1007/s40005-017-0381-1

Stem cell-based therapies for HIV/AIDS
journal, August 2016


A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
journal, October 2016


CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
journal, April 2019


CRISPR-mediated genome editing and human diseases
journal, December 2016


CRISPR-Mediated Editing of the B Cell Receptor in Primary Human B Cells
journal, February 2019


Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
journal, September 2016


Delivery of Cas9 Protein into Mouse Zygotes through a Series of Electroporation Dramatically Increases the Efficiency of Model Creation
journal, May 2016

  • Wang, Wenbo; Kutny, Peter M.; Byers, Shannon L.
  • Journal of Genetics and Genomics, Vol. 43, Issue 5
  • DOI: 10.1016/j.jgg.2016.02.004

CRISPR/Cas9: Transcending the Reality of Genome Editing
journal, June 2017


CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome
journal, June 2017

  • Bloh, Kevin M.; Bialk, Pawel A.; Gopalakrishnapillai, Anilkumar
  • Molecular Therapy - Nucleic Acids, Vol. 7
  • DOI: 10.1016/j.omtn.2017.04.009

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
journal, September 2018


Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
journal, December 2018


Efficient Gene Editing at Major CFTR Mutation Loci
journal, June 2019


Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
journal, April 2017


Genome-editing Technologies for Gene and Cell Therapy
journal, March 2016

  • Maeder, Morgan L.; Gersbach, Charles A.
  • Molecular Therapy, Vol. 24, Issue 3
  • DOI: 10.1038/mt.2016.10

Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
journal, August 2017


Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo
journal, August 2018


Reprogramming human T cell function and specificity with non-viral genome targeting
journal, July 2018


A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
journal, August 2018

  • Vakulskas, Christopher A.; Dever, Daniel P.; Rettig, Garrett R.
  • Nature Medicine, Vol. 24, Issue 8
  • DOI: 10.1038/s41591-018-0137-0

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
journal, April 2017


Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time
journal, June 2017


CRISPR/Cas9 editing reveals novel mechanisms of clustered microRNA regulation and function
journal, August 2017


Simultaneous electroporation and dielectrophoresis in non-electrolytic micro/nano-electroporation
journal, February 2018


CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
journal, May 2018


Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
journal, August 2018


A comparison of inverted and upright laser-activated titanium nitride micropyramids for intracellular delivery
journal, October 2018


Co-expression of Cas9 and single-guided RNAs in Escherichia coli streamlines production of Cas9 ribonucleoproteins
journal, May 2019


Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair
journal, December 2019

  • Sansbury, Brett M.; Hewes, Amanda M.; Kmiec, Eric B.
  • Communications Biology, Vol. 2, Issue 1
  • DOI: 10.1038/s42003-019-0705-y

Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides
journal, September 2016

  • Bialk, Pawel; Sansbury, Brett; Rivera-Torres, Natalia
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep32681

A vector platform for the rapid and efficient engineering of stable complex transgenes
journal, October 2016

  • Jäckel, Carsten; Nogueira, Melanie Schmitt; Ehni, Nadja
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep34365

GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells
journal, November 2016

  • Fazil, Mobashar Hussain Urf Turabe; Ong, Seow Theng; Chalasani, Madhavi Latha Somaraju
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep37721

Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange
journal, April 2017

  • Kelton, William; Waindok, Ann Cathrin; Pesch, Theresa
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep45775

Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
journal, December 2017

  • Lessard, Samuel; Francioli, Laurent; Alfoldi, Jessica
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 52
  • DOI: 10.1073/pnas.1714640114

Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL
journal, March 2018

  • Wu, Yanfang; Li, Xia; Jia, Junying
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 12
  • DOI: 10.1073/pnas.1716439115

Metabolic reprogramming of human CD8 + memory T cells through loss of SIRT1
journal, November 2017

  • Jeng, Mark Y.; Hull, Philip A.; Fei, Mingjian
  • The Journal of Experimental Medicine, Vol. 215, Issue 1
  • DOI: 10.1084/jem.20161066

Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
journal, February 2018

  • Seki, Akiko; Rutz, Sascha
  • Journal of Experimental Medicine, Vol. 215, Issue 3
  • DOI: 10.1084/jem.20171626

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos
journal, June 2016

  • Kouranova, Evguenia; Forbes, Kevin; Zhao, Guojun
  • Human Gene Therapy, Vol. 27, Issue 6
  • DOI: 10.1089/hum.2016.009

Discovery of an autoimmunity-associated IL2RA enhancer by unbiased targeting of transcriptional activation
posted_content, December 2016

  • Simeonov, Dimitre R.; Gowen, Benjamin G.; Boontanrart, Mandy
  • BioRxiv
  • DOI: 10.1101/091843

Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR)
journal, December 2019


An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
journal, January 2018

  • Dewari, Pooran Singh; Southgate, Benjamin; Mccarten, Katrina
  • eLife
  • DOI: 10.1101/255737

The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis
journal, March 2018

  • Melamed, Anat; Yaguchi, Hiroko; Miura, Michi
  • eLife
  • DOI: 10.1101/277335

Mapping gene regulatory networks of primary CD4+ T cells using single-cell genomics and genome engineering
posted_content, June 2019

  • Gate, Rachel E.; Kim, Min Cheol; Lu, Andrew
  • BioRxiv
  • DOI: 10.1101/678060

Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing
journal, December 2019


A CRISPR-Based Toolbox for Studying T Cell Signal Transduction
journal, January 2016

  • Chi, Shen; Weiss, Arthur; Wang, Haopeng
  • BioMed Research International, Vol. 2016
  • DOI: 10.1155/2016/5052369

The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
journal, August 2019

  • Sanches-da-Silva, Gabriela De Nardi; Medeiros, Luiza Fonseca Sales; Lima, Fabio Mitsuo
  • International Journal of Genomics, Vol. 2019
  • DOI: 10.1155/2019/8458263

Primary allogeneic mitochondrial mix (PAMM) transfer/transplant by MitoCeption to address damage in PBMCs caused by ultraviolet radiation
journal, June 2019


Translational research—the need of a new bioethics approach
journal, January 2016

  • Hostiuc, Sorin; Moldoveanu, Alin; Dascălu, Maria-Iuliana
  • Journal of Translational Medicine, Vol. 14, Issue 1
  • DOI: 10.1186/s12967-016-0773-4

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
journal, February 2018

  • Li, Xiaolei; Shao, Changshun; Shi, Yufang
  • Journal of Hematology & Oncology, Vol. 11, Issue 1
  • DOI: 10.1186/s13045-018-0578-4

Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage
journal, February 2017


Strategies for precision modulation of gene expression by epigenome editing: an overview
journal, September 2015


Chimeric antigen receptor T cell therapy for multiple myeloma
journal, June 2019


Targeting the latent reservoir to achieve functional HIV cure
journal, May 2016


Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent
journal, January 2018


In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
journal, July 2018


CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna
journal, October 2017


A versatile system for rapid multiplex genome-edited CAR T cell generation
journal, February 2017


Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection
journal, March 2019

  • Albers, Julian J.; Ammon, Tim; Gosmann, Dario
  • Life Science Alliance, Vol. 2, Issue 2
  • DOI: 10.26508/lsa.201900367

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
journal, March 2019

  • Xiao, Qiaoqiao; Guo, Deyin; Chen, Shuliang
  • Frontiers in Cellular and Infection Microbiology, Vol. 9
  • DOI: 10.3389/fcimb.2019.00069

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
journal, December 2018


Editing the Central Nervous System Through CRISPR/Cas9 Systems
journal, May 2019

  • Cota-Coronado, Agustin; Díaz-Martínez, Néstor Fabián; Padilla-Camberos, Eduardo
  • Frontiers in Molecular Neuroscience, Vol. 12
  • DOI: 10.3389/fnmol.2019.00110

CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling
journal, September 2015

  • Torres-Ruiz, Raul; Rodriguez-Perales, Sandra
  • International Journal of Molecular Sciences, Vol. 16, Issue 9
  • DOI: 10.3390/ijms160922151

RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
journal, February 2016

  • Unniyampurath, Unnikrishnan; Pilankatta, Rajendra; Krishnan, Manoj
  • International Journal of Molecular Sciences, Vol. 17, Issue 3
  • DOI: 10.3390/ijms17030291

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
journal, May 2018

  • Farboud, Behnom; Jarvis, Erin; Roth, Theodore L.
  • Journal of Visualized Experiments, Issue 135
  • DOI: 10.3791/57350-v

CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
journal, June 2018

  • Baliou, Stella; Adamaki, Maria; Kyriakopoulos, Anthony
  • International Journal of Oncology
  • DOI: 10.3892/ijo.2018.4434

An Overview Of The Crispr-Based Genomic- And Epigenome-Editing System: Function, Applications, And Challenges
journal, January 2019

  • Mojarrad, Majid; Bozorg Qomi, Saeed; Asghari, Amir
  • Advanced Biomedical Research, Vol. 8, Issue 1
  • DOI: 10.4103/abr.abr_41_19

Efficient And Versatile Crispr Engineering Of Human Neurons In Culture To Model Neurological Disorders
text, January 2016


Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
journal, November 2018